Login / Signup

Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.

Jonathan M SpergelMirna ChehadeEvan S DellonAlbert J BredenoordXian SunLila GlotfeltyArsalan ShabbirSarette T TiltonEilish McCann
Published in: The American journal of gastroenterology (2024)
Dupilumab reduced the impact of EoE on multiple aspects of HRQoL, patients' impression of dysphagia, and frequency and severity of symptoms beyond dysphagia in adults/adolescents with EoE.
Keyphrases
  • atopic dermatitis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • young adults
  • chronic kidney disease
  • prognostic factors
  • sleep quality
  • patient reported outcomes
  • chronic rhinosinusitis